Gurubasavaraja Swamy Purawarga Matada

16PUBLICATIONS
32CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targetsIndustrial microbiology (incl. biofeedstocks)Human impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 09, 2026
Rational Design, Synthesis, Biological Evaluation, and In Silico Study of N-Cinnamamide/Benzamide-(4-(Substituted Phenyl)-6-(4-Cyclohexylphenyl)pyrimidin-2-Yl) Derivatives as EGFR Inhibitors Targeting EGFRWT, EGFRT790M, and EGFRL858R /T790M/C797S in NSCLC.

|Aug 31, 2026
Design, Synthesis, and Molecular Docking Studies of Coumarin-chalcone Conjugates as Selective TNF-α and Weak COX-2 Inhibitors with Efficacy as an Antioxidant.

|Jun 19, 2026
Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure-activity relationship insights.

|Feb 25, 2026
Medicinal chemistry perspective of chalcone derivatives as anticancer agents: synthetic strategy, biological activity, and structure-activity relationship.

Aryadipto Dasgupta, R Rajesh, Pronoy Kanti Das

|Dec 03, 2025
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives.

Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal

|Apr 21, 2025
In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies.

Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar

Pageof 3

Frequent Collaborators

11 joint publications

Rohit Pal

6 joint publications

Ghanshyam Teli

5 joint publications

Prasad Sanjay Dhiwar

5 joint publications

Sindhuja Sengupta